Treatment of Herpetic Whitlow in Pediatric Patients

Introduction to Treatment

• The Centers for Disease Control and Prevention recommends treating pediatric patients with herpetic whitlow using oral acyclovir 20 mg/kg per dose (maximum 400 mg/dose) three times daily for 5-10 days, continuing until lesions completely heal 1, 2

Treatment Algorithm

• For mild disease, the American Academy of Pediatrics suggests oral acyclovir 20 mg/kg per dose (maximum 400 mg/dose) three times daily for 5-10 days, with monitoring for clinical improvement within 48-72 hours 1, 2, 3
• The Infectious Diseases Society of America recommends continuing therapy until lesions completely heal, not just until improvement begins, representing AI-level evidence (strong recommendation based on clinical trial data) 1

Moderate to Severe Disease

• The Centers for Disease Control and Prevention advises starting with IV acyclovir 5-10 mg/kg per dose three times daily, then transitioning to oral acyclovir at the same weight-based dosing after lesions begin to regress 1, 2
• The American Academy of Pediatrics recommends continuing oral therapy until complete healing occurs 1

Acyclovir-Resistant Cases

• The Infectious Diseases Society of America suggests using IV foscarnet 40 mg/kg per dose three times daily for patients who fail to respond to acyclovir, which is uncommon in immunocompetent children but should be considered if no improvement after 5-7 days of appropriate acyclovir therapy 3, 4, 5

Special Populations

• For neonates, the American Academy of Pediatrics recommends using IV acyclovir 20 mg/kg every 8 hours, with higher dosing than older children, and ensuring adequate hydration during treatment 3

Alternative Therapies

• The Centers for Disease Control and Prevention notes that valacyclovir and famciclovir are approved for adolescents who can swallow adult-sized tablets, but no pediatric formulations exist and dosing data in young children are limited 1, 2